MWCPX Performance — Tcw Metwest Unconstrained Bond Fund, Plan Class
Data updated: 2026-08-27
MWCPX returned +1.79% year to date and +5.22% over one year to Jun 2026. Annualised returns are +6.85% over 3 years and +2.92% over 5 years. The fund beat its Short-Term Securitized Bond category average: $100 invested three years ago grew to $122, against $120 for the category, and to $105 over one year, against $105. Volatility over the past three years was 3.43% a year. In the 12 months to Jun 2026 the fund took in a net $8.9M, and assets reached $2.68B.
MWCPX Growth of $100
What $100 invested in Tcw Metwest Unconstrained Bond Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Short-Term Securitized Bond category average over the same months.
| Period | MWCPX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $105 | $105 |
| 3 years (Jul 2023 – Jun 2026) | $122 | $120 |
| 5 years (Jul 2021 – Jun 2026) | $115 | $117 |
| Since data start (Mar 2020 – Jun 2026) | $121 | $124 |
MWCPX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.79% |
| 1 year | +5.22% |
| 3 years (annualised) | +6.85% |
| 5 years (annualised) | +2.92% |
MWCPX Annual Returns
Calendar-year total returns of Tcw Metwest Unconstrained Bond Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +1.79% |
| 2025 | +8.04% |
| 2024 | +6.15% |
| 2023 | +7.82% |
| 2022 | −8.06% |
| 2021 | +1.09% |
| 2020 (Mar–Dec) | +3.73% |
MWCPX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.5% | +0.6% | −0.7% | +0.6% | +0.5% | +0.2% | — | — | — | — | — | — |
| 2025 | +0.7% | +1.5% | +0.2% | +0.2% | +0.7% | +1.2% | +0.2% | +1.0% | +0.8% | +0.6% | +0.5% | +0.2% |
| 2024 | +0.7% | −0.5% | +1.1% | −1.4% | +1.4% | +0.9% | +1.8% | +1.4% | +1.3% | −1.2% | +1.0% | −0.4% |
| 2023 | +3.0% | −1.5% | +1.6% | +0.6% | −0.4% | 0.0% | +0.7% | +0.1% | −1.1% | −1.1% | +3.2% | +2.7% |
| 2022 | −0.9% | −1.1% | −1.9% | −1.9% | −0.1% | −2.4% | +2.0% | −0.8% | −2.9% | −0.7% | +2.2% | +0.3% |
| 2021 | +0.4% | −0.1% | −0.3% | +0.6% | +0.4% | +0.2% | +0.3% | +0.1% | −0.1% | −0.3% | −0.4% | +0.2% |
| 2020 | — | — | −6.9% | +2.6% | +1.9% | +1.7% | +1.5% | +0.5% | +0.1% | +0.4% | +1.4% | +0.7% |
MWCPX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 3.43%
- 3-year Sharpe ratio: 0.68 (vs 4.5% risk-free rate)
- Best month: +3.23% (Nov 2023)
- Worst month: −1.39% (Apr 2024)
MWCPX Fund Flows
Monthly money in and out of Tcw Metwest Unconstrained Bond Fund, from SEC Form N-PORT.
- 12-month net flow: $8.9M
- 12-month gross sales (incl. reinvestments): $676.1M
- Sales ÷ redemptions: 1.01×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $43.4M | $57.2M | −$13.8M |
| May 2026 | $43.2M | $28.2M | $15.0M |
| Apr 2026 | $50.3M | $36.2M | $14.2M |
| Mar 2026 | $41.2M | $40.0M | $1.1M |
| Feb 2026 | $71.3M | $102.4M | −$31.1M |
| Jan 2026 | $106.8M | $31.6M | $75.3M |
| Dec 2025 | $62.0M | $176.6M | −$114.6M |
| Nov 2025 | $44.4M | $29.1M | $15.3M |
| Oct 2025 | $48.8M | $53.6M | −$4.7M |
| Sep 2025 | $61.2M | $44.1M | $17.1M |
| Aug 2025 | $46.9M | $22.8M | $24.1M |
| Jul 2025 | $56.7M | $45.6M | $11.0M |
MWCPX Assets Under Management
Net assets of Tcw Metwest Unconstrained Bond Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $2.68B |
| 2026-03-31 | $2.66B |
| 2025-12-31 | $2.64B |
| 2025-09-30 | $2.75B |
| 2025-06-30 | $2.67B |
| 2025-03-31 | $2.73B |
| 2024-12-31 | $2.59B |
| 2024-09-30 | $2.66B |
| 2024-06-28 | $2.53B |
| 2024-03-28 | $2.57B |
| 2023-12-29 | $2.59B |
| 2023-09-29 | $2.61B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.